Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug 21;19(1):148.
doi: 10.1186/s12881-018-0580-2.

Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation

Affiliations
Case Reports

Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation

Yubi Lin et al. BMC Med Genet. .

Abstract

Background: Sudden cardiac death (SCD) induced by malignant ventricular tachycardia (MVT) among young adults with right ventricular cardiomyopathy/dysplasia (ARVC/D) is a devastating event. Parts of ARVC/D patients have a mutation in genes encoding components of cardiac desmosomes, such as desmoglein-2 (DSG2), plakophilin-2 and desmoplakin.

Case presentation: Here we report a potentially pathogenic mutation in the DSG2 gene, which was identified in a family with ARVC/D using Whole Exome Sequencing (WES) and Sanger Sequencing. In all, Patient III:1 with ARVC/D carried the compound heterozygous mutations of DSG2 p.F531C and KCNE5 p.D92E/E93X, which were both inherited from her mother (II:2), who died of SCD. Carriers of DSG2p.F531C showed various phenotypes, such as ARVC/D, SCD, MVT and dilated cardiomyopathy. For III:1, there were significant low-voltage regions in the inferior-apical, inferior-lateral wall of the right ventricular epicardium and outflow tracts of the right ventricle. Under the guidance of a three-dimensional mapping system, MVT was successfully ablated with an epicardial-endocardial approach targeting for late, double or fragmental potentials after implantable cardioverter-defibrillator (ICD) electrical storms. No VT recurrence was observed during the one year of follow-up.

Conclusions: When coexisting with heterozygous KCNE5 p.D92E/E93X, heterozygous DSG2 p.F531C as a genetic background was found to predispose to ARVC/D, SCD and MVT, which were successfully ablated using an epicardial-endocardial approach.

Keywords: Arrhythmogenic right ventricular cardiomyopathy/dysplasia; Electrical storm; Genetics; Sudden cardiac death; Ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was approved by the Guangdong Medical Institutional Review Board and Medical Ethics Committees [No.GDREC2016001H (R1)]. All participants gave informed consent and the parents consented on behalf of the minors and deceased participants.

Consent for publication

The written informed consent or parental consent to the medical information and images for publication was obtained from all participants. The parents consented on behalf of the minors and deceased participants.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Pedigree Charts
Fig. 2
Fig. 2
ECGs characteristics of III:1 patient. a Inversion of T wave (V1-V3 leads) in sinus rhythm; Pairs of ventricular premature beat origin from right ventricular tract; cardiac counterclockwise transposition. b Clinical episode of persistent and malignant ventricular tachycardia origin from the inflow-free wall of right ventricle. cd Ventricular programed stimulation induced short episode of ventricular tachycardia origin from the inflow-free wall (c) and outflow tract of right ventricle (d), during first ablation in the other hospital
Fig. 3
Fig. 3
Cardiac CT images of III:1 patient. Four-chamber view of non-enhanced image (a) and enhanced image (b). Thinning of the anterior wall of the right ventricle with extensive fatty infiltration (arrow) could be noted. The short-axis view (c) demonstrated dilation of the right ventricle (star). Enlargement of the right atrium (stars) was shown on the axial view (d)
Fig. 4
Fig. 4
Pathogenic mutations in the DSG2 protein and structure of KCNE5 mutations. a secondary structure of DSG2 protein (NP_001934.2), which consists of 1118 amino acids. The pathogenic mutation related to ARVC/D, hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) were displayed according to PubMed ClinVar and recent reports from PubMed. b-d primary (b) and tertiary (cd) structure changes of KCNE5 p.D92E/E93X mutation and wildtype of KCNE5, constructed by Swiss-model. *, stop-gain
Fig. 5
Fig. 5
Electrical and anatomical mapping with guidance of CARTO system. a Endocardial mapping of both ventricles, showed in anterior-posterior position. b Endocardial mapping of both ventricles, showed in posterior–anterior positions. cd Epicardial mapping indicated that there were obvious low-voltage regions or scars with significant late, double or fragmented potentials, around the tricuspid annulus, in inferior-lateral-apex and inferior-apex walls (cd), and outflow tract (e) of right ventricle. Line and lamellar ablation was performed across the scars (red points). F, in the mid-septum of endocardium in the right ventricle, the pacing mapping suggested potential targets, as ECG characteristics of pacing similar to that of short episodes of clinical VT. This region was mapped with significant late potentials and ablated (red points)

References

    1. Sato T, Nishio H, Suzuki K. Sudden death during exercise in a juvenile with arrhythmogenic right ventricular cardiomyopathy and desmoglein-2 gene substitution: a case report. Leg Med (Tokyo) 2011;13(6):298–300. doi: 10.1016/j.legalmed.2011.08.004. - DOI - PubMed
    1. Kaltman JR, Thompson PD, Lantos J, et al. Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group. Circulation. 2011;123(17):1911–1918. doi: 10.1161/CIRCULATIONAHA.110.017228. - DOI - PubMed
    1. Quarta G, Muir A, Pantazis A, et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123(23):2701–2709. doi: 10.1161/CIRCULATIONAHA.110.976936. - DOI - PubMed
    1. den Haan AD, Tan BY, Zikusoka MN, et al. Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet. 2009;2(5):428–435. doi: 10.1161/CIRCGENETICS.109.858217. - DOI - PMC - PubMed
    1. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108(25):3084–3091. doi: 10.1161/01.CIR.0000103130.33451.D2. - DOI - PubMed

Publication types

Supplementary concepts

LinkOut - more resources